/wp-content/uploads/2019/07/NKMAX_AMERICA-300x215.png00Su Lei Yee/wp-content/uploads/2019/07/NKMAX_AMERICA-300x215.pngSu Lei Yee2021-02-04 14:39:512021-02-04 14:40:27NKMax America Announces Key Leadership Appointment
/wp-content/uploads/2019/07/NKMAX_AMERICA-300x215.png00Denise Chua/wp-content/uploads/2019/07/NKMAX_AMERICA-300x215.pngDenise Chua2020-10-20 11:21:312020-10-20 11:21:31Affimed and NKMax America to Study the Combination of AFM24, an EGFR-Targeted Innate Cell Engager, with SNK01 Natural Killer Cell Therapy
/wp-content/uploads/2019/07/NKMAX_AMERICA-300x215.png00Denise Chua/wp-content/uploads/2019/07/NKMAX_AMERICA-300x215.pngDenise Chua2020-09-08 16:05:582020-09-08 16:06:16NKMax America Announces a Clinical Trial Collaboration and Supply Agreement with Merck KGaA, Darmstadt, Germany and Pfizer
/wp-content/uploads/2019/07/NKMAX_AMERICA-300x215.png00Denise Chua/wp-content/uploads/2019/07/NKMAX_AMERICA-300x215.pngDenise Chua2020-08-31 11:27:072020-08-31 11:27:07NKMax America Receives FDA Clearance to Amend its Current Phase I Monotherapy Trial to Include an Additional New Cohort of SNK01 + Checkpoint Inhibitor in Refractory Solid Tumors.
/wp-content/uploads/2019/07/NKMAX_AMERICA-300x215.png00Denise Chua/wp-content/uploads/2019/07/NKMAX_AMERICA-300x215.pngDenise Chua2020-06-02 10:37:282020-06-02 10:37:28NKMax America Receives FDA Clearance of IND for Phase I/2a Trial of their Natural Killer Cell Therapy (SNK01) in Combination with Trastuzumab or Cetuximab for the Treatment of Advanced/Metastatic HER2- or EGFR- Expressing Cancers
/wp-content/uploads/2019/07/NKMAX_AMERICA-300x215.png00Denise Chua/wp-content/uploads/2019/07/NKMAX_AMERICA-300x215.pngDenise Chua2020-04-30 18:07:482020-04-30 18:07:48NKMax America To Present Data from Natural Killer Cell Immunotherapy Clinical Program at the ASCO20 Virtual Scientific Program
/wp-content/uploads/2019/07/NKMAX_AMERICA-300x215.png00Denise Chua/wp-content/uploads/2019/07/NKMAX_AMERICA-300x215.pngDenise Chua2020-03-31 19:13:442020-03-31 19:18:07NKMax America Announces Acceptance of Three Abstracts at the American Society of Clinical Oncology (ASCO) Annual Meeting
/wp-content/uploads/2019/07/NKMAX_AMERICA-300x215.png00Denise Chua/wp-content/uploads/2019/07/NKMAX_AMERICA-300x215.pngDenise Chua2020-03-17 10:00:352020-03-18 23:10:45NKMax America to Present at the Upcoming NIH-AACR Cancer, Autoimmunity, and Immunology Conference
/wp-content/uploads/2019/07/NKMAX_AMERICA-300x215.png00Aurelia Yee/wp-content/uploads/2019/07/NKMAX_AMERICA-300x215.pngAurelia Yee2020-03-09 23:05:122020-03-09 23:05:12NKMax America to Present at Immuno-Oncology Summit Europe 2020
/wp-content/uploads/2019/07/NKMAX_AMERICA-300x215.png00Aurelia Yee/wp-content/uploads/2019/07/NKMAX_AMERICA-300x215.pngAurelia Yee2020-03-03 22:45:472020-03-06 05:41:32NKMax America to Present Corporate Overview at the Cowen & Company 40th Annual Health Care Conference
/wp-content/uploads/2019/07/NKMAX_AMERICA-300x215.png00Aurelia Yee/wp-content/uploads/2019/07/NKMAX_AMERICA-300x215.pngAurelia Yee2019-09-09 05:48:562020-03-06 05:49:07NKMax America Announces New cGMP Manufacturing Facility for Production of SNK Cell Therapy
/wp-content/uploads/2019/07/NKMAX_AMERICA-300x215.png00Aurelia Yee/wp-content/uploads/2019/07/NKMAX_AMERICA-300x215.pngAurelia Yee2019-08-13 05:42:432020-03-06 05:47:49NKMax America Doses First Subject in Phase I Trial of SNK in Patients with Refractory Cancer
/wp-content/uploads/2019/07/NKMAX_AMERICA-300x215.png00David Anderson/wp-content/uploads/2019/07/NKMAX_AMERICA-300x215.pngDavid Anderson2019-03-19 08:00:152020-03-06 05:44:12NKMax America to Present at 2019 Innate Immunity Conference
/wp-content/uploads/2019/07/NKMAX_AMERICA-300x215.png00Aurelia Yee/wp-content/uploads/2019/07/NKMAX_AMERICA-300x215.pngAurelia Yee2019-03-05 05:41:512020-03-06 05:45:47NKMax America Announces FDA Approval of IND for Phase 1 Trial of SNK01 in Patients with Refractory Cancer
NKMax Events
Check back soon for upcoming events!
NKMax on Social Media
Follow NKMax on social media to keep up-to-date on the latest company news and the science of Natural Killer cells!
NKMax America Announces Key Leadership Appointment
/in Press Release /by Su Lei Yee